Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease

Published:2017-08-16 Issue:4 Volume:102 Page:633-641
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Hindryckx Pieter¹,Novak Gregor²,Bonovas Stefanos³,Peyrin-Biroulet Laurent⁴,Danese Silvio³⁵

Affiliation:

1. Department of Gastroenterology; University of Ghent; Ghent Belgium

2. Department of Gastroenterology; Ljubljana University Medical Centre; Ljubljana Slovenia

3. Department of Gastroenterology; IBD Center, Humanitas Clinical and Research Center; Milan Italy

4. Inserm U954; University Hospital of Nancy, Lorraine University; Vandoeuvre-lès-Nancy France

5. Department of Biomedical Sciences; Humanitas University; Milan Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference75 articles.

1. Redeeming an old foe: protective as well as pathophysiological roles for tumor necrosis factor in inflammatory bowel disease;Dube;Am. J. Physiol. Gastrointest. Liver Physiol.,2015

2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial;Hanauer;Lancet,2002

3. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2014

4. Risk for overall infection with anti-TNF and anti-integrin agents used in IBD: a systematic review and meta-analysis;Shah;Inflamm. Bowel Dis.,2017

5. Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis;Bonovas;Clin. Gastroenterol. Hepatol.,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?;Expert Opinion on Biological Therapy;2024-06-02

2. Lung abscess in a non-compliant patient with Crohn�s disease;Revista Española de Enfermedades Digestivas;2024

3. Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2023-02-16

4. Transcriptomic analyses of treatment-naïve pediatric ulcerative colitis patients and exploration of underlying disease pathogenesis;Journal of Translational Medicine;2023-01-16

5. Efficacy and safety of biosimilar versus originator infliximab in patients with inflammatory bowel disease: A real-world cohort analysis;Indian Journal of Gastroenterology;2022-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3